| | |

Insights from European Mesothelioma Databases

Insights from European Mesothelioma Databases

An international team of researchers analyzed data from two mesothelioma databases. They discovered trends about mesothelioma in Europe. These trends can help doctors make better treatment decisions for their patients.

Improving Mesothelioma Treatment

Mesothelioma is a type of cancer that is both rare and aggressive. It is caused by exposure to a toxic mineral called asbestos. Asbestos is a fiber-like material that can be used in building and manufacturing materials.

The two most common types of mesothelioma are pleural and peritoneal. Pleural mesothelioma is found in the lining of the lungs. Peritoneal mesothelioma grows in the abdominal cavity. There are about 2,000 cases of pleural mesothelioma and 1,000 cases of peritoneal mesothelioma each year.

There are also three different cell types of mesothelioma. About half of mesotheliomas are epithelioid and have the best prognosis. Ten percent of mesotheliomas are sarcomatoid and usually have the worst prognosis. The rest of mesothelioma cases are a mix of both cell types.

When a person is diagnosed with mesothelioma, their doctor will try to figure out what cell type they have before figuring out a treatment plan. The treatment plan usually includes surgery, chemotherapy, and radiation.

Lessons Learned from European Data Analysis

For this study, researchers looked at two mesothelioma databases in European populations. They used the European Thoracic Oncology Platform Mesoscape and the European Society of Thoracic Surgeons databases. They wanted to learn more about the characteristics of mesothelioma, how it spreads, and how it is treated.

The researchers found that most patients had the epithelioid cell type of mesothelioma. Many were in the advanced stages of the disease.

The researchers followed up with a group of patients for an average of about four years and found that the average survival time was about 17 months. They also discovered that certain factors were associated with longer survival times. These included being a woman, having the epithelioid subtype, and being in a lower stage of the disease.

Patients who received a combination of treatments, including surgery, tended to have longer survival times compared to those who received palliative care. This was especially true for patients who had surgery to remove the tumor completely.

This study shares important information about the characteristics and treatment options for mesothelioma, and it can help doctors make better decisions for their patients.

Source

Opitz I, Bille A, Dafni U, et al. European Epidemiology of Pleural Mesothelioma – Real-life data from a joint analysis of the Mesoscape database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma database [published online ahead of print, 2023 Jun 23]. J Thorac Oncol. 2023;S1556-0864(23)00632-9. doi:10.1016/j.jtho.2023.06.011. https://pubmed.ncbi.nlm.nih.gov/37356802/

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…